Literature DB >> 17318774

Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome.

S Hahn1, S Tan, S Sack, R Kimmig, B Quadbeck, K Mann, O E Janssen.   

Abstract

The aim of our study was to evaluate the prevalence of the metabolic syndrome (MBS) according to the current International Diabetes Federation definition in German PCOS women. Four hundred and eleven PCOS patients (age 28+/-6.3 years) and 82 controls (age 28+/-7.5 years) were evaluated for anthropometric and metabolic parameters by physical examination, blood testing and a personal interview including family history. A subgroup analysis of controls with BMI-matched PCOS women (BMI 22.9+/-2.8 kg/m (2)) was performed to detect PCOS specific differences in metabolic variables between the groups. The MBS was found in 33.8% of PCOS women compared to 7.3% in the control group. Parameters of insulin resistance, lipid-and glucose metabolism, mean values of all criteria of the MBS as well as the prevalence of the MBS were significantly different between the entire PCOS cohort and controls, but did not differ between BMI-matched PCOS women and controls. In addition, the prevalence of the MBS increased with age. Moreover, in PCOS women an increase in BMI and insulin resistance was accompanied by a further significant increase in the severity of clinical and biochemical hyperandrogenism. In PCOS women, while one out of three PCOS women had the MBS, the presence of metabolic abnormalities did not appear to be associated with PCOS per se, but rather correlated with age and the degree of obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318774     DOI: 10.1055/s-2007-967093

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  13 in total

Review 1.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Authors:  Lara C Morley; Thomas Tang; Ephia Yasmin; Robert J Norman; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

2.  Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India.

Authors:  Kavita Mandrelle; Mohan S Kamath; Dian J Bondu; Achamma Chandy; Tk Aleyamma; Korula George
Journal:  J Hum Reprod Sci       Date:  2012-01

3.  Evaluation of adolescents for polycystic ovary syndrome in an urban population.

Authors:  Sarabeth Broder-Fingert; Bina Shah; Marion Kessler; Melissa Pawelczak; Raphael David
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-05-05

4.  The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome.

Authors:  Jie Chen; Shanmei Shen; Yong Tan; Dong Xia; Yanjie Xia; Yunxia Cao; Wenjun Wang; Xiaoke Wu; Hongwei Wang; Long Yi; Qian Gao; Yong Wang
Journal:  J Ovarian Res       Date:  2015-03-22       Impact factor: 4.234

5.  A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).

Authors:  Maha H Daghestani; Mazin Daghestani; Mamoon Daghistani; Akmal El-Mazny; Geir Bjørklund; Salvatore Chirumbolo; Samar H Al Saggaf; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-08-21       Impact factor: 3.876

Review 6.  Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Jamal Hallajzadeh; Maliheh Khoramdad; Nahid Karamzad; Amir Almasi-Hashiani; Ali Janati; Erfan Ayubi; Reza Pakzad; Mark J M Sullman; Saeid Safiri
Journal:  J Cardiovasc Thorac Res       Date:  2018-05-28

7.  Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A prospective study of PCOS women.

Authors:  Sujata Kar
Journal:  J Hum Reprod Sci       Date:  2013-07

8.  Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome.

Authors:  Tao Tao; Bing Xu; Wei Liu
Journal:  Reprod Biol Endocrinol       Date:  2013-10-21       Impact factor: 5.211

9.  Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study.

Authors:  Yuying Wang; Wei Zhou; Chunhua Wu; Yi Zhang; Tzuchun Lin; Yun Sun; Wei Liu; Tao Tao
Journal:  Reprod Biol Endocrinol       Date:  2018-03-27       Impact factor: 5.211

10.  Impact of Central Obesity on Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization.

Authors:  Yu Li; Haiyan Lin; Ping Pan; Dongzi Yang; Qingxue Zhang
Journal:  Biores Open Access       Date:  2018-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.